BridgeBio is demonstrably improved this development of an innovative solution for ATTR-CM, utilizing the compound. Preliminary clinical information suggests promising outcomes for those affected from a serious disease. The emphasis represents researchers’ commitment to addressing unmet healthcare needs in this cardiology space. Attruby: BridgeBi